Market open
Penumbra/$PEN
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Penumbra
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
Ticker
$PEN
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
4,200
Website
Penumbra Metrics
BasicAdvanced
$11B
309.50
$0.89
0.54
-
Price and volume
Market cap
$11B
Beta
0.54
52-week high
$277.89
52-week low
$148.00
Average daily volume
439K
Financial strength
Current ratio
5.821
Quick ratio
3.049
Long term debt to equity
19.217
Total debt to equity
20.528
Interest coverage (TTM)
51.73%
Management effectiveness
Return on assets (TTM)
3.33%
Return on equity (TTM)
3.13%
Valuation
Price to earnings (TTM)
309.5
Price to revenue (TTM)
9.111
Price to book
9.52
Price to tangible book (TTM)
11.29
Price to free cash flow (TTM)
79.021
Growth
Revenue change (TTM)
16.96%
Earnings per share change (TTM)
-15.96%
3-year revenue growth (CAGR)
17.88%
3-year earnings per share growth (CAGR)
-0.53%
What the Analysts think about Penumbra
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Penumbra stock.
Penumbra Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Penumbra Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Penumbra News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Penumbra stock?
Penumbra (PEN) has a market cap of $11B as of January 27, 2025.
What is the P/E ratio for Penumbra stock?
The price to earnings (P/E) ratio for Penumbra (PEN) stock is 309.5 as of January 27, 2025.
Does Penumbra stock pay dividends?
No, Penumbra (PEN) stock does not pay dividends to its shareholders as of January 27, 2025.
When is the next Penumbra dividend payment date?
Penumbra (PEN) stock does not pay dividends to its shareholders.
What is the beta indicator for Penumbra?
Penumbra (PEN) has a beta rating of 0.54. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.